Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

Background: Chronic hepatitis C (CHC) is associated with hepatic and extrahepatic complications, including cardiovascular disease (CVD). The effects of sustained virological response (SVR) and liver fibrosis on CVD risk are not well established. Aims: We aim to assess the dynamics of Fibrosis-4 (FIB...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramadan, Mohammad Said, Boccia, Filomena, Moretto, Simona Maria, De Gregorio, Fabrizio, Gagliardi, Massimo, Iossa, Domenico, Durante-Mangoni, Emanuele, Zampino, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572655/
https://www.ncbi.nlm.nih.gov/pubmed/36233646
http://dx.doi.org/10.3390/jcm11195781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572655/
https://www.ncbi.nlm.nih.gov/pubmed/36233646
http://dx.doi.org/10.3390/jcm11195781

Ejemplares similares